Elizabeth Pršić describes her mother Andrea’s pancreatic cancer treatment. Andrea has the BRCA2 mutation, which helps determine the plan.
Oncologist Allyson Ocean, M.D., introduces Let’s Win, an interactive website for pancreatic cancer patients to learn about new treatments.
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
Gene therapy combined with standard first-line chemotherapy treatment forms a clinical trial for metastatic pancreatic cancer.
David Dessert explains that his aunt’s genetic testing for BRCA2 mutation directed his own treatment for pancreatic cancer.
Can the immunotherapy combination of cancer vaccines and a checkpoint blockade drug work against metastatic pancreatic cancer?
Sharon Seibel knew she had the BRCA2 mutation but was unaware of the link to pancreatic cancer. Her chemotherapy was one for BRCA carriers.